SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-15-412477
Filing Date
2015-12-23
Accepted
2015-12-23 14:15:55
Documents
17
Period of Report
2015-12-21
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d104127d8k.htm 8-K 15769
2 EX-99.1 d104127dex991.htm EX-99.1 31332
3 GRAPHIC g1041271.jpg GRAPHIC 166346
4 GRAPHIC g10412710.jpg GRAPHIC 186563
5 GRAPHIC g10412711.jpg GRAPHIC 224734
6 GRAPHIC g10412712.jpg GRAPHIC 138355
7 GRAPHIC g10412713.jpg GRAPHIC 125505
8 GRAPHIC g10412714.jpg GRAPHIC 212425
9 GRAPHIC g10412715.jpg GRAPHIC 65408
10 GRAPHIC g1041272.jpg GRAPHIC 226590
11 GRAPHIC g1041273.jpg GRAPHIC 288418
12 GRAPHIC g1041274.jpg GRAPHIC 298349
13 GRAPHIC g1041275.jpg GRAPHIC 143834
14 GRAPHIC g1041276.jpg GRAPHIC 99289
15 GRAPHIC g1041277.jpg GRAPHIC 64033
16 GRAPHIC g1041278.jpg GRAPHIC 132694
17 GRAPHIC g1041279.jpg GRAPHIC 185083
  Complete submission text file 0001193125-15-412477.txt   3526741
Mailing Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024
Business Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024 (424) 248-6500
PUMA BIOTECHNOLOGY, INC. (Filer) CIK: 0001401667 (see all company filings)

IRS No.: 770683487 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35703 | Film No.: 151305303
SIC: 2834 Pharmaceutical Preparations